Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hugo Ten Cate

Showing results (41-50 of 461) with videos related to

Pageof 47
Sort By:
European Heart Journal|October 8, 2024
Non-vitamin K oral anticoagulants in valvular heart disease before surgery: a tale of bridging vs. no bridgingRaffaele De Caterina, Hugo Ten Cate, Vittorio Pengo
Frontiers in Cardiovascular Medicine|June 14, 2019
Editorial: Novel and potential markers for prediction of outcome in patients with acute and chronic coronary heart diseaseHugo Ten Cate, Frederic Kontny, Dennis W Nilsen
Blood Reviews|May 2, 2013
The role of tissue factor pathway inhibitor in atherosclerosis and arterial thrombosisKristien Winckers, Hugo ten Cate, Tilman M Hackeng
Advances in Cardiology|August 22, 2012
Challenges in atrial fibrillationRon Pisters, Hugo Ten Cate, Harry J Crijns
Trends in Molecular Medicine|July 6, 2006
Signal transduction induced by activated protein C: no role in protection against sepsis?Sjoukje H Slofstra, Hugo ten Cate, C Arnold Spek
Journal of Thrombosis and Thrombolysis|November 19, 2013
Thrombin generation and atherosclerosisJana Kalz, Hugo ten Cate, Henri M H Spronk
Seminars in Thrombosis and Hemostasis|February 16, 2006
Tissue factor in infection and severe inflammationMarcel Levi, Tom van der Poll, Hugo ten Cate
Frontiers in Cardiovascular Medicine|June 14, 2024
Editorial: Novel and potential biomarkers for prediction of outcome in patients with chronic and acute coronary heart disease, volume IIDennis W T Nilsen, Frederic Kontny, Hugo Ten Cate
Critical Care Medicine|May 11, 2002
Endothelium: interface between coagulation and inflammationMarcel Levi, Hugo ten Cate, Tom van der Poll
Thrombosis Journal|August 26, 2006
Low dose endotoxin priming is accountable for coagulation abnormalities and organ damage observed in the Shwartzman reaction. A comparison between a single-dose endotoxemia model and a double-hit endotoxin-induced Shwartzman reactionSjoukje H Slofstra, Hugo ten Cate, C Arnold Spek
Pageof 47

Showing results (41-50 of 461) with videos related to

Sort By:
Pageof 47
European Heart Journal|October 8, 2024
Non-vitamin K oral anticoagulants in valvular heart disease before surgery: a tale of bridging vs. no bridgingRaffaele De Caterina, Hugo Ten Cate, Vittorio Pengo
Frontiers in Cardiovascular Medicine|June 14, 2019
Editorial: Novel and potential markers for prediction of outcome in patients with acute and chronic coronary heart diseaseHugo Ten Cate, Frederic Kontny, Dennis W Nilsen
Blood Reviews|May 2, 2013
The role of tissue factor pathway inhibitor in atherosclerosis and arterial thrombosisKristien Winckers, Hugo ten Cate, Tilman M Hackeng
Advances in Cardiology|August 22, 2012
Challenges in atrial fibrillationRon Pisters, Hugo Ten Cate, Harry J Crijns
Trends in Molecular Medicine|July 6, 2006
Signal transduction induced by activated protein C: no role in protection against sepsis?Sjoukje H Slofstra, Hugo ten Cate, C Arnold Spek
Journal of Thrombosis and Thrombolysis|November 19, 2013
Thrombin generation and atherosclerosisJana Kalz, Hugo ten Cate, Henri M H Spronk
Seminars in Thrombosis and Hemostasis|February 16, 2006
Tissue factor in infection and severe inflammationMarcel Levi, Tom van der Poll, Hugo ten Cate
Frontiers in Cardiovascular Medicine|June 14, 2024
Editorial: Novel and potential biomarkers for prediction of outcome in patients with chronic and acute coronary heart disease, volume IIDennis W T Nilsen, Frederic Kontny, Hugo Ten Cate
Critical Care Medicine|May 11, 2002
Endothelium: interface between coagulation and inflammationMarcel Levi, Hugo ten Cate, Tom van der Poll
Thrombosis Journal|August 26, 2006
Low dose endotoxin priming is accountable for coagulation abnormalities and organ damage observed in the Shwartzman reaction. A comparison between a single-dose endotoxemia model and a double-hit endotoxin-induced Shwartzman reactionSjoukje H Slofstra, Hugo ten Cate, C Arnold Spek
Pageof 47